To join this case, fill out the form below
Freshworks Inc. Investigation
By clicking on the Submit button below, I acknowledge that I have read the Retainer Agreement and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
By clicking on the Submit button below, I acknowledge that I have read the Derivative Retention Letter and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
A signed Retainer Agreement will be sent to your email shortly.
Oops! Something went wrong while submitting the form.

Freshworks Inc. Investigation

We are investigating possible breaches of fiduciary duty and violations of the federal securities laws by, among others, the Board of Directors and senior officers of Freshworks Inc. (NASDAQ: FRSH) (“Freshworks” or the “Company”) concerning misleading statements and omissions connected with the Company’s initial public offering (“IPO”).

On September 22, 2021, Freshworks sold 28.5 million shares of its common stock at $36 per share in an IPO.  Currently, the stock trades more than 65% less than the IPO price, having dropped as low as 70% below the IPO price.  In the post-IPO period, the Company reported only flat or decelerated growth, revenue, and billings. Analysts have correspondingly significantly reduced their stock price targets for the Company.

Weiss Law has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients.  For more information about the firm, please go to: http://www.weisslaw.co

Other Cases

May 9, 2024

DecisionPoint Systems, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of DecisionPoint Systems, Inc. (“DecisionPoint” or the “Company”) (NYSE: DPSI), in connection with its acquisition by affiliates of Barcoding Holdings, LLC. Under the merger agreement, the Company’s shareholders will receive $10.22 per share.

Join Case →

May 9, 2024

Deciphera Pharmaceuticals, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Deciphera Pharmaceuticals, Inc. (“Deciphera” or the“Company”) (NASDAQ: DCPH), in connection with its acquisition by ONO Pharmaceutical, Co., Ltd. via tender offer. Under the merger agreement, the Company’s shareholders will receive $25.60 per share.

Join Case →

May 9, 2024

U.S. Silica Holdings, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of U.S. Silica Holdings, Inc. (“U.S. Silica” or the “Company”) (NYSE: SLCA), in connection with its acquisition by affiliates of Apollo Global Management, Inc. (NYSE: APO). Under the merger agreement, the Company’s shareholders will receive $15.50 per share. The transaction is valued at approximately $1.85 billion.

Join Case →

Where to find us?

new york

305 Broadway, 7th FI
New York, NY 10007
(212) 682-3025

california

8383 Wilshire Blvd., Suite 935
Beverly Hills, CA 90211
(310) 208-2800

georgia

476 Hardendorf Ave. NE
Atlanta, GA 30307
(404) 692-7910

NEW JERSEY

4 Brighton Rd, Suite. 204
Clifton, NJ 07012

Copyright 2022 Weiss Law. All rights reserved

Attorney AdvertisingLegal

Design by Cramdyn